Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Bracco and Dibra team up on the development of new MRI agents

Oct. 15, 1999

Alliance seeks FDA approval for new ultrasound contrast agent

Oct. 15, 1999

DuPont acquires ImaRx

Oct. 13, 1999

Emory U. develops metal chelates for renal imaging with advantageous properties

Oct. 13, 1999

NC-100100 is safe and well tolerated in target group of patients

Oct. 8, 1999

Axonyx to develop AD diagnostic test based on Australian technology

Oct. 7, 1999

Manganese chelates disclosed by Bracco, Dibra for MRI contrast imaging

Oct. 6, 1999

Medco initiates phase II trial of MRE-0470

Oct. 4, 1999

Sonus and Nycomed Amersham establish ultrasound contrast agreement

Oct. 1, 1999

Chiron licenses HCV patent rights to Abbott

Sep. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...